We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Requests Additional Data for Genentech's Avastin Application
FDA Requests Additional Data for Genentech's Avastin Application
September 12, 2006
The FDA is requesting that Genentech provide an update of the company’s clinical data for the use of Avastin to treat breast cancer, the company announced Sept. 11.